Role of a Pediatric Cardiologist in the COVID-19 Pandemic
- PMID: 33015722
- PMCID: PMC7533115
- DOI: 10.1007/s00246-020-02476-y
Role of a Pediatric Cardiologist in the COVID-19 Pandemic
Abstract
Coronavirus disease 2019 (COVID-19) has affected patients across all age groups, with a wide range of illness severity from asymptomatic carriers to severe multi-organ dysfunction and death. Although early reports have shown that younger age groups experience less severe disease than older adults, our understanding of this phenomenon is in continuous evolution. Recently, a severe multisystem inflammatory syndrome in children (MIS-C), with active or recent COVID-19 infection, has been increasingly reported. Children with MIS-C may demonstrate signs and symptoms of Kawasaki disease, but also have some distinct differences. These children have more frequent and severe gastrointestinal symptoms and are more likely to present with a shock-like presentation. Moreover, they often present with cardiovascular involvement including myocardial dysfunction, valvulitis, and coronary artery dilation or aneurysms. Here, we present a review of the literature and summary of our current understanding of cardiovascular involvement in children with COVID-19 or MIS-C and identifying the role of a pediatric cardiologist in caring for these patients.
Keywords: COVID-19; Cardiovascular; MIS-C; Pediatric.
Conflict of interest statement
The authors have indicated they have no potential conflicts of interest to disclose. Authors have indicated they have no financial relationships relevant to this article to disclose.
Figures



Similar articles
-
Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.World J Pediatr. 2021 Aug;17(4):335-340. doi: 10.1007/s12519-021-00435-y. Epub 2021 May 20. World J Pediatr. 2021. PMID: 34013488 Free PMC article. Review.
-
Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.Rheumatol Int. 2021 Jan;41(1):19-32. doi: 10.1007/s00296-020-04749-4. Epub 2020 Nov 21. Rheumatol Int. 2021. PMID: 33219837 Free PMC article. Review.
-
COVID-19 in children: Pathogenesis and current status.Allergy Asthma Proc. 2021 Jan 3;42(1):8-15. doi: 10.2500/aap.2021.42.200104. Allergy Asthma Proc. 2021. PMID: 33404385
-
Multisystem Inflammatory Syndrome in Children (MIS-C).Curr Allergy Asthma Rep. 2022 May;22(5):53-60. doi: 10.1007/s11882-022-01031-4. Epub 2022 Mar 22. Curr Allergy Asthma Rep. 2022. PMID: 35314921 Free PMC article. Review.
-
Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.Curr Rheumatol Rep. 2021 Jul 3;23(8):58. doi: 10.1007/s11926-021-01028-4. Curr Rheumatol Rep. 2021. PMID: 34216296 Free PMC article. Review.
Cited by
-
An 11-Year-Old Saudi Arabian Girl Who Presented with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection with Coronary Artery Aneurysm and Cardiac Involvement: A Case Report.Am J Case Rep. 2021 Sep 12;22:e933053. doi: 10.12659/AJCR.933053. Am J Case Rep. 2021. PMID: 34510156 Free PMC article.
-
Increased number of electrocardiogram findings requiring additional cardiac examination in young athletes during the coronavirus disease 2019 pandemic: a case series.J Int Med Res. 2021 Oct;49(10):3000605211053280. doi: 10.1177/03000605211053280. J Int Med Res. 2021. PMID: 34693778 Free PMC article.
-
The Evaluation of Troponin I Levels and Myocarditis in Children with COVID-19: A Pediatric Single-Center Experience.Pediatr Cardiol. 2023 Apr;44(4):873-881. doi: 10.1007/s00246-022-03017-5. Epub 2022 Oct 9. Pediatr Cardiol. 2023. PMID: 36210385 Free PMC article.
-
Recent research trends in Kawasaki disease-related infection.Clin Exp Pediatr. 2022 Nov;65(11):538-539. doi: 10.3345/cep.2022.00696. Epub 2022 Jul 22. Clin Exp Pediatr. 2022. PMID: 35879868 Free PMC article. No abstract available.
-
Echocardiographic screening in pediatric asymptomatic or paucisymptomatic coronavirus disease 2019 outpatients: is it a useful test or an excess of zeal?J Cardiovasc Med (Hagerstown). 2024 Mar 1;25(3):234-238. doi: 10.2459/JCM.0000000000001549. Epub 2023 Aug 8. J Cardiovasc Med (Hagerstown). 2024. PMID: 37577859 Free PMC article.
References
-
- Global Surveillance for human infection with coronavirus disease (COVID-19) https://www.who.int/publications-detail/global-surveillance-for-human-in.... Accessed 1 June 2020
-
- Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, Heidemann SM, Kleinman LC, Sen AI, Hall MW, Priestley MA, McGuire JK, Boukas K, Sharron MP, Burns JP, Collaborative ftIC-P Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020 doi: 10.1001/jamapediatrics.2020.1948. - DOI - PMC - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical